跳至主要内容
临床试验/NCT01208532
NCT01208532已完成不适用

Quality of Life in Patients With Stem Cell Transplant After High Dose Chemotherapy: Validation Study of the Korean Version of the EORTC QLQ-HDC29

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 226 人开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
226
试验地点
1
主要终点
Reliability and validity of the Korean version of the EORTC HDC-29

研究概览

简要总结

The aim of this study is to evaluate the reliability and validity of the Korean version of the European Organization for Research and Treatment of Cancer High-dose Chemotherapy module (EORTC HDC-29).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are aged more than 18 years
  • Patients who are diagnosed with hematologic malignancies and who are planned to receive high-dose chemotherapy followed by allogeneic or autologous stem cell transplantation (SCT)
  • Patients who agree with the informed consent

排除标准

  • Patients who are unable to complete the questionnaire due to the serious physical or psychological morbidity

结局指标

主要结局

Reliability and validity of the Korean version of the EORTC HDC-29

时间窗: at the patient's hospitalization (before the SCT) and the outpatient clinic (three, six, and 12 months after their SCT)

Relaibility; Cronbach's alpha coefficient is used to evaluate the internal consistency. Validity; Persons's correlation coefficient is used to examine the correlation between similar dimensions of the different questionnaires.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sung-Soo Yoon

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验